Stealth BioTherapeutics (MITO) OLE Data is Transformational, Nomura Reiterates $28 PT
Tweet Send to a Friend
Nomura/Instinet analyst Christopher Marai reiterated a Buy rating and $28.00 price target on Stealth BioTherapeutics (NASDAQ: MITO) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
